FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

20449011000001101: Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69001301000001114 Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69001401000001118 Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Has VMP Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Has basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (Drug Tariff Special Order) 200 ml Is a True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Inferred relationship Existential restriction modifier
MagnaPhos 121.25mg/5ml (5mmol/5ml) oral solution (TriOn Pharma Ltd) 200 ml Is a True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start